Discontinued — last reported Q3 '25
DexCom Investment Proceeds increased by 14.3% to $468.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 28.0%, from $650.20M to $468.20M. Over 4 years (FY 2021 to FY 2025), Investment Proceeds shows a downward trend with a -5.1% CAGR.
An increase suggests the liquidation of assets to raise cash, while a decrease indicates a strategy of holding investments to maturity or reinvesting.
This metric represents the cash inflows from the sale or maturity of marketable securities and other financial investmen...
Often mirrors the purchase of investments; peers use these inflows to manage working capital fluctuations or fund strategic initiatives.
proceeds_from_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $838.30M | $537.00M | $501.00M | $241.80M | $543.80M | $602.20M | $740.00M | $697.60M | $859.40M | $671.40M | $719.00M | $1.12B | $666.80M | $630.60M | $405.20M | $650.20M | $638.70M | $466.20M | $409.60M | $468.20M |
| QoQ Change | — | -35.9% | -6.7% | -51.7% | +124.9% | +10.7% | +22.9% | -5.7% | +23.2% | -21.9% | +7.1% | +56.0% | -40.6% | -5.4% | -35.7% | +60.5% | -1.8% | -27.0% | -12.1% | +14.3% |
| YoY Change | — | — | — | — | -35.1% | +12.1% | +47.7% | +188.5% | +58.0% | +11.5% | -2.8% | +60.8% | -22.4% | -6.1% | -43.6% | -42.0% | -4.2% | -26.1% | +1.1% | -28.0% |